Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

α/Sulfono-γ-AA peptide hybrids agonist of GLP-1R with prolonged action both in vitro and in vivo

Acta Pharmaceutica Sinica B(2022)10.1016/j.apsb.2022.10.014Source: DataRank Database

α/Sulfono-γ-AA peptide hybrids agonist of GLP-1R with prolonged action both in vitro and in vivo is a research paper published in Acta Pharmaceutica Sinica B (2022). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldTopics (15)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Candy Lee,Peng Sang ORCID,Zaid Amso ORCID,David Huang ORCID,Weixia Zhong

Live enrichment

PubMed:37139407 PMC:PMC10149899

National Institutes of Health

Grant: R01 AG056569

National Institutes of Health

Grant: R01AI152416

National Institutes of Health

Grant: 5R01AI152416-09

Antimicrobial agents derived from AApeptide biomaterials

National Institutes of Health

Grant: 5R01AG056569-04

Gamma-AApeptides as novel biomaterials inhibiting Abeta peptide aggregation

goldLicense: cc-by-nc-nd

publisherhttps://doi.org/10.1016/j.apsb.2022.10.014

publisherhttps://api.elsevier.com/content/article/PII:S2211383522004397?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211383522004397?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10149899/pdf/main.pdf

repositoryhttps://doaj.org/article/91dc5f2999f64c208779cc3f9f338555

Fields of Study

0301 basic medicine01 natural sciences0104 chemical sciences03 medical and health sciences

Keywords

StabilityPharmacological activityGlp-1Peptidomimeticsrational designHelical StructuresGlp-1r AgonistsType-2 Diabetes TreatmentsRM1-950Original ArticleTherapeutics. Pharmacology

Sustainable Development Goals

SDG 3: 3. Good health